Home
>
US Stocks
>
Marinus Pharmaceuticals Inc
Marinus Pharmaceuticals Inc
MRNS

Marinus Pharmaceuticals Inc

$11.464.58%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
11.79
Today Low/High
11.45 / 11.91
52 Week Low/High
$6.92 / $20.04
Market Cap
$442.25M

Company Details

Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders. Ganaxolone is a positive allosteric modulator of GABAA receptors that acts on a well-characterized target in the brain known to have anti-seizure, anti-depressant and anti-anxiety potential. Ganaxolone is being developed in IV and oral dose forms intended to maximize therapeutic reach to adult and pediatric patient populations in both acute and chronic care settings. Marinus recently completed the first ever Phase 3 pivotal trial in children with CDKL5 deficiency disorder and is conducting a Phase 3 trial in refractory status epilepticus, Phase 2 trial in tuberous sclerosis complex and a Phase 2 biomarker-driven proof-of-concept trial in PCDH19-related epilepsy.
Organisation
Marinus Pharmaceuticals Inc
Employees
69
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Marinus Pharmaceuticals Inc share price today

Can Indians buy Marinus Pharmaceuticals Inc shares?

How can I buy Marinus Pharmaceuticals Inc shares from India?

Can Fractional shares of Marinus Pharmaceuticals Inc be purchased?

What are the documents required to start investing in Marinus Pharmaceuticals Inc stocks?

We are a SEBI registered investement advisor